Trending intel short linkNo signup · Email subscription
43.3k following · Innovative Drug / China / Hair Loss Treatment

Approval timeline for the new domestic anti-hair loss drug KX-826

Follow up on the progress of KX-826's NDA submission to the National Medical Products Administration, acceptance status, review process, arrangements for supplementary information submission, and the final approval and listing timeline.

43.3k following104.1k views
By clicking “Confirm”, you acknowledge that you have read and agree to
/ /
Unlimited Free Public IntelligenceOnly key changes trigger emailsUnsubscribe anytime
Monitor official signalsTrack announcements, filings, company statements, prices, and investor updates.
AI summaryFilter repeated noise and provide concise conclusions with source confidence.
Notify only when usefulNo daily spam. You only get emailed when meaningful progress appears.